AMSTERDAM, the Netherlands -- Embolization of large spontaneous portosystemic shunts can relieve refractory hepatic encephalopathy and can keep many patients free of it for the long term as long as ...

February 20, 2007 — The US Food and Drug Administration (FDA) has approved a vascular shunt for temporarily restoring blood flow to severely injured limbs, a molecular test to assess the risk for ...

MANCHESTER, England, April 28  Spontaneous cerebral blood clots appear to be a common pathology of Alzheimer's disease and vascular dementia, and they may be targets for prevention or treatment ...

New successes in printing vascular tissue from living cells point to the accelerating pace of development of 3D-printing tissue — and eventually the ability to manufacture organs from small samples of ...

Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according ...

There is a persistent lack of effective treatments for heart failure with preserved ejection fraction (HFpEF), so in this study, investigators examined the impact of an atrial shunt among patients ...

Of six patients with diffuse glomerulonephritis and associated infected ventriculoatrial shunt, three had improved renal function after removal of the infected shunt, and three died from ...

Acquired SEPS are associated with portal hypertension, cirrhosis, and complications of decompensation. In particular, the effects of NVEPS on portal pressure are variable, but there is evidence of ...

The U.S. Food and Drug Administration (FDA) today cleared for U.S. marketing a vascular shunt, a medical device that can help save the arms and legs of soldiers critically injured in combat as well as ...